Showing results (101-110 of 215) with videos related to
Sort By:
Pageof 22
Annals of the Rheumatic Diseases|December 1, 1987
Association of persisting IgA response with yersinia triggered reactive arthritis: a study on 104 patientsA Toivanen, R Lahesmaa-Rantala, R Vuento, et al.Annals of the Rheumatic Diseases|February 1, 1987
Circulating yersinia specific immune complexes after acute yersiniosis: a follow up study of patients with and without reactive arthritisR Lahesmaa-Rantala, K Granfors, R Kekomäki, et al.British Journal of Rheumatology|December 16, 1998
Pogosta disease: clinical observations during an outbreak in the province of North Karelia, FinlandM Turunen, P Kuusisto, P E Uggeldahl, et al.Rheumatology International|January 1, 1997
High frequency of Yersinia antibodies in healthy populations in Finland and GermanyO Mäki-Ikola, J Heesemann, A Toivanen, et al.Acta Endocrinologica|September 1, 1988
IgA class antibodies against Yersinia enterocolitica O:3 in patients with thyroid diseaseR Leino, R Lahesmaa-Rantala, K Granfors, et al.Scandinavian Journal of Rheumatology. Supplement|January 1, 1988
Rheumatoid factors in Yersinia-triggered reactive arthritisK Granfors, R Lahesmaa-Rantala, A Toivanen, et al.Journal of Ocular Pharmacology|January 1, 1988
Timolol binding to bovine ocular melanin in vitroP Aula, T Kaila, R Huupponen, et al.Acta Ophthalmologica|February 1, 1987
The pharmacokinetics of ocularly applied timolol in rabbitsR Huupponen, T Kaila, L Salminen, et al.Pharmacology & Toxicology|April 4, 1998
Systemic and ocular absorption and antagonist activity of topically applied cyclopentolate in manM Haaga, T Kaila, L Salminen, et al.Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|January 1, 1995
Corneal vascularization and opacification during long-term use of dipivefrinL Salminen, K Krootila, H Helin, et al.Pageof 22